140 related articles for article (PubMed ID: 2686415)
21. Ciprofloxacin versus ceftazidime in skin and soft tissue infections.
Thadepalli H; Mathai D; Chuah SK; Bansal MB
J Chemother; 1989 Feb; 1(1):30-4. PubMed ID: 2656929
[TBL] [Abstract][Full Text] [Related]
22. [Comparative study of cefpirome and ceftazidime in complicated urinary tract infections].
Naide Y; Aso Y; Oshi M; Kumamoto Y; Hirose T; Machida T; Tsuchida S; Suzuki K; Orikasa S; Kawada Y
Hinyokika Kiyo; 1991 Apr; 37(4):447-64. PubMed ID: 1892004
[TBL] [Abstract][Full Text] [Related]
23. Comparison of intravenous ciprofloxacin with ceftazidime in the treatment of serious soft tissue infections.
Tice AD; Marsh PK; Craven PC
Diagn Microbiol Infect Dis; 1990; 13(2):165-7. PubMed ID: 2196153
[No Abstract] [Full Text] [Related]
24. Comparison of intravenous fleroxacin with ceftazidime for treatment of complicated urinary tract infections.
Cox CE
Am J Med; 1993 Mar; 94(3A):118S-125S. PubMed ID: 8452167
[TBL] [Abstract][Full Text] [Related]
25. Sequential therapy with ofloxacin in complicated urinary tract infections: a randomized comparative study with ciprofloxacin.
Peters HJ
Infection; 1992; 20(3):172-3. PubMed ID: 1644496
[No Abstract] [Full Text] [Related]
26. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study.
Carmeli Y; Armstrong J; Laud PJ; Newell P; Stone G; Wardman A; Gasink LB
Lancet Infect Dis; 2016 Jun; 16(6):661-673. PubMed ID: 27107460
[TBL] [Abstract][Full Text] [Related]
27. Safety of intravenous ciprofloxacin. A review.
Arcieri GM; Becker N; Esposito B; Griffith E; Heyd A; Neumann C; O'Brien B; Schacht P
Am J Med; 1989 Nov; 87(5A):92S-97S. PubMed ID: 2686431
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study.
Vazquez JA; González Patzán LD; Stricklin D; Duttaroy DD; Kreidly Z; Lipka J; Sable C
Curr Med Res Opin; 2012 Dec; 28(12):1921-31. PubMed ID: 23145859
[TBL] [Abstract][Full Text] [Related]
29. Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Flaherty JP; Waitley D; Edlin B; George D; Arnow P; O'Keefe P; Weinstein RA
Am J Med; 1989 Nov; 87(5A):278S-282S. PubMed ID: 2686429
[TBL] [Abstract][Full Text] [Related]
30. Cefpirome versus ceftazidime in the treatment of urinary tract infections.
J Antimicrob Chemother; 1992 Apr; 29 Suppl A():95-104. PubMed ID: 1601765
[TBL] [Abstract][Full Text] [Related]
31. Oral ciprofloxacin versus intravenous therapy with other non-quinolone agents: a study of 291 infections.
Lorian V; Pavletich K
Drugs Exp Clin Res; 1994; 20(5):209-14. PubMed ID: 7875058
[TBL] [Abstract][Full Text] [Related]
32. An open trial of ceftazidime in the treatment of complicated urinary tract infections.
Matos Ferreira A; Coelho H; de Carvalho MP
J Int Med Res; 1984; 12(6):361-3. PubMed ID: 6394406
[TBL] [Abstract][Full Text] [Related]
33. [Clinical results and safety of ceftazidime, a new injectable cephalosporin, in long-term administration of the treatment of infections in urology].
Suzuki K; Tamai H; Naide Y; Fujita T; Ogawa T; Yanaoka M; Nagakubo I; Moriguchi R; Okishio N; Ishiguro K
Hinyokika Kiyo; 1984 Nov; 30(11):1711-35. PubMed ID: 6397060
[TBL] [Abstract][Full Text] [Related]
34. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
[TBL] [Abstract][Full Text] [Related]
35. Pharmacoeconomic comparison of sequential IV/oral ciprofloxacin versus ceftazidime in the treatment of nosocomial pneumonia.
Paladino JA
Can J Hosp Pharm; 1995 Oct; 48(5):276-83. PubMed ID: 10152782
[TBL] [Abstract][Full Text] [Related]
36. Explorative Randomized Phase II Clinical Study of the Efficacy and Safety of Finafloxacin versus Ciprofloxacin for Treatment of Complicated Urinary Tract Infections.
Wagenlehner F; Nowicki M; Bentley C; Lückermann M; Wohlert S; Fischer C; Vente A; Naber K; Dalhoff A
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29339395
[TBL] [Abstract][Full Text] [Related]
37. Ciprofloxacin in patients with bacteremic infections. The Spanish Group for the Study of Ciprofloxacin.
Bouza E; Díaz-López MD; Bernaldo de Quirós JC; Rodríguez-Créixems M
Am J Med; 1989 Nov; 87(5A):228S-231S. PubMed ID: 2589366
[TBL] [Abstract][Full Text] [Related]
38. Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group.
Modai J
Am J Med; 1989 Nov; 87(5A):243S-247S. PubMed ID: 2686426
[TBL] [Abstract][Full Text] [Related]
39. [Ciprofloxacin in the treatment of chronic urinary tract infections].
Sozzo E; Patruno P; Mastrangelo F
Clin Ter; 1988 Mar; 124(5):363-8. PubMed ID: 2974346
[No Abstract] [Full Text] [Related]
40. Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost.
Angeli P; Guarda S; Fasolato S; Miola E; Craighero R; Piccolo F; Antona C; Brollo L; Franchin M; Cillo U; Merkel C; Gatta A
Aliment Pharmacol Ther; 2006 Jan; 23(1):75-84. PubMed ID: 16393283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
